Sirgo Mark A's Form 4/A amendment
AmendedBiodelivery Sciences International Inc (BDSI) · filed Nov 19, 2021
- Accession no.
- 0001103021-21-000118
- Filed
- Nov 19, 2021
- Trade date
- Nov 18, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Nov 19, 2021
This filing lists 1 non-derivative transaction. Open-market purchases total $30.4K. It was filed 1 day after the trade.
This amendment replaces 0001103021-21-000116 (filed Nov 19, 2021).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sirgo Mark ACIK 0001301715 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2021 | Common Stock | PPurchaseAcquired | +10,000 | $3.04 | +$30,400 | 1,140,595 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This Form 4/A is being filed to amend the Form 4 filed on November 19, 2021 (the "Original Form 4"). The Original Form 4 incorrectly used transaction code "S," instead of transaction code "P."